Diabetes News and Research

Latest Diabetes News and Research

Monitoring blood glucose levels with contact lenses may soon be a reality for diabetes patients

Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing colours - replacing the need to routinely draw blood throughout the day.

22 Dec 2009

LA BioMed physician-researchers named Super Doctors in the Los Angeles Magazine

Los Angeles Magazine, in its January issue, will name 37 of the physician-researchers at Los Angeles Biomedical Research Institute (LA BioMed) to be among Southern California Super Doctors.

22 Dec 2009

Endocannabinoid modulation of sweet taste receptors may help control feeding behavior

Sweet taste responses were enhanced by endocannabinoids in every case. The effect was specific for sweet taste, as endocannibinoids had no effect on responses to sour, salty, bitter or umami taste stimuli.

22 Dec 2009

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

An international study authored by a UT Southwestern Medical Center researcher has concluded that the anemia drug darbepoetin alfa works no better than a placebo in several other applications previously thought to be promising.

22 Dec 2009

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that it has received European CE mark approval for the EndoBarrier™, a non-surgical therapy to treat type 2 diabetes and obesity. The CE marking (an acronym for the French "Conformite Europeenne") certifies that a product has met EU requirements for marketing in Europe. Clinical trials involving more than 270 patients have demonstrated the significant weight loss and diabetes improvement achieved with the EndoBarrier Gastrointestinal Liner.

22 Dec 2009

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

Arena Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for lorcaserin, Arena's internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss. The submission is based on an extensive data package from lorcaserin's clinical development program that includes 18 clinical trials totaling 8,576 patients.

22 Dec 2009

OSI Pharmaceuticals provides update to ODAC meeting

OSI Pharmaceuticals, Inc. today provided an update to the preliminary revenue and adjusted earnings per share growth rate guidance provided to investors at the Company’s recent analyst R&D day meeting on December 3, 2009. The Company now believes that the 2010 overall revenue percentage growth rate will be in the mid-teens and re-affirms that adjusted earnings per share will grow at 10% or more.

22 Dec 2009

iGuard registers 2 million subscribers in just over 2 years

iGuard, a drug safety system that monitors patient medications for drug interactions, safety alerts and recalls, today announced it has registered 2 million subscribers in just over 2 years - matching the early growth rate of the popular social networking tool Twitter.

22 Dec 2009

Health and education leaders commend school for promoting physical activity among students

During a visit today to Conrad Weiser Middle School, Department of Health Secretary Everette James and Secretary of Education Gerald Zahorchak commended the school for its efforts to increase physical activity among students.

22 Dec 2009

Veolia Energy North America signs long-term agreement to operate MATEP assets in Boston

Veolia Energy North America, a leading provider of sustainable energy services, management solutions, and facility operations is pleased to announce that it has entered into a long-term agreement to operate and maintain the Medical Area Total Energy Plant (MATEP) assets in the Longwood Medical Area of Boston.

22 Dec 2009

Genome-wide study of African and African-American ancestry released by scientists

People who identify as African-American may be as little as 1 percent West African or as much as 99 percent, just one finding of a large-scale, genome-wide study of African and African-American ancestry released today.

22 Dec 2009

Researchers use hydrogels to induce significant vasculature growth in areas of damaged tissue

Regenerative medicine therapies often require the growth of functional, stable blood vessels at the site of an injury. Using synthetic polymers called hydrogels, researchers at the Georgia Institute of Technology have been able to induce significant vasculature growth in areas of damaged tissue.

22 Dec 2009

ZEGERID OTC approval triggers $20M milestone payment to Santarus

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009.

22 Dec 2009

DMC launches Dental Optimizer, a free online application connected to Microsoft HealthVault

While politicians and pundits continue to arm wrestle the minutiae of health reform, more and more Americans are stepping up to take charge of their own health.

22 Dec 2009

Medical students from TCOM offer health screening for homeless

Medical students from the Texas College of Osteopathic Medicine (TCOM) offered a health screening for the homeless Friday, Dec. 11, in an effort to give back to the people of Tarrant County.

22 Dec 2009

Cost outweighs benefits of self-monitoring blood glucose test strips

Routine self-monitoring of blood glucose levels by people with type 2 diabetes who are not taking insulin is an ineffective use of health resources as the modest benefits are outweighed by the significant cost of test strips, suggest 2 studies http://www.cmaj.ca/embargo/cmaj091017.pdf and http://www.cmaj.ca/embargo/cmaj090765.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca .

22 Dec 2009

Omega-3 fatty acids lower AMD and chronic kidney disease, improve heart health

Start 2010 right: consume more seafood omega-3 fatty acids. Improvements or lower risks in age-related macular degeneration (AMD), chronic kidney disease and heart health have been reported in people with higher intakes of fatty fish or the omega-3s they contain.

22 Dec 2009

Amylin Pharmaceuticals' modified exendins and exendin agonists patent: USPTO issues Final Office Action

ConjuChem Biotechnologies Inc. announced today that the U.S. Patent & Trademark Office (USPTO) has issued a Right of Appeal Notice (Final Office Action) in the inter partes reexamination of Patent No. 6,924,264. The patent, entitled "Modified Exendins and Exendin Agonists," was issued in August 2005 and is assigned to Amylin Pharmaceuticals, Inc. The Action once again rejected all the subject claims for obviousness and/or lack of novelty. The inter partes reexamination in the USPTO does not involve any of ConjuChem's patents.

22 Dec 2009

Reference platform for diabetic retinopathy and other vascular complications

The volume addresses a variety of current scientific discussions about mechanisms of damage such as growth factors and the VEGF/PEDF balance in the diabetic eye, the ocular renin-angiotensin system, and leukocyte interactions with the microvasculature among others.

22 Dec 2009

Jamie Oliver to receive the 2010 TED Prize

Jamie Oliver, celebrity chef and standard-bearer in the fight against obesity and other diet related issues, has been announced as the recipient of the 2010 TED Prize, an award granting recipients $100,000 and something much bigger - an opportunity to realize a wish to change the world.

22 Dec 2009

Diabetes News and Research

Latest Diabetes News and Research

Monitoring blood glucose levels with contact lenses may soon be a reality for diabetes patients

LA BioMed physician-researchers named Super Doctors in the Los Angeles Magazine

Endocannabinoid modulation of sweet taste receptors may help control feeding behavior

Darbepoetin alfa does not reduce cardiovascular problem in anemic patients on dialysis

GI Dynamics' EndoBarrier non-surgical type 2 diabetes therapy receives European CE mark approval

Arena Pharmaceuticals submits lorcaserin NDA to the FDA

OSI Pharmaceuticals provides update to ODAC meeting

iGuard registers 2 million subscribers in just over 2 years

Health and education leaders commend school for promoting physical activity among students

Veolia Energy North America signs long-term agreement to operate MATEP assets in Boston

Genome-wide study of African and African-American ancestry released by scientists

Researchers use hydrogels to induce significant vasculature growth in areas of damaged tissue

ZEGERID OTC approval triggers $20M milestone payment to Santarus

DMC launches Dental Optimizer, a free online application connected to Microsoft HealthVault

Medical students from TCOM offer health screening for homeless

Cost outweighs benefits of self-monitoring blood glucose test strips

Omega-3 fatty acids lower AMD and chronic kidney disease, improve heart health

Amylin Pharmaceuticals' modified exendins and exendin agonists patent: USPTO issues Final Office Action

Reference platform for diabetic retinopathy and other vascular complications

Jamie Oliver to receive the 2010 TED Prize

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in